Arno Therapeutics, Inc. filed its 10-K on Mar 31, 2015 for the period ending Dec 31, 2014. In this report its auditor, Crowe Horwath LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0003 USD | +417.24% | -.--% | +200.00% |
2017 | Arno Therapeutics, Inc. Terminates Licensing Agreement with Ohio State University | CI |
2017 | Arno Therapeutics Seeks Acquisitions | CI |
1st Jan change | Capi. | |
---|---|---|
+200.00% | 14.8K | |
-2.95% | 90.75B | |
-1.97% | 39.03B | |
-15.47% | 31.85B | |
+61.09% | 26.26B | |
-22.81% | 14.13B | |
-8.82% | 12.87B | |
-11.77% | 11.6B | |
-45.97% | 10.91B | |
+3.07% | 8.89B |
- Stock Market
- Equities
- ARNI Stock
- News Arno Therapeutics, Inc.
- Arno Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt